AGRX Archives - Market Exclusive

Home Tags AGRX

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material...

ME Staff 8-k - March 2, 2021

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Results of Operations and...

ME Staff 8-k - January 14, 2021

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material...

ME Staff 8-k - May 5, 2020

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Other Events

ME Staff 8-k - February 21, 2020

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material...

ME Staff 8-k - February 12, 2020

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Results of Operations and...

ME Staff 8-k - January 8, 2020

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by Maxim...

ME Staff - November 1, 2019

Agile Therapeutics,Inc. (NASDAQ:AGRX) Files An 8-K Other Events

ME Staff 8-k - March 19, 2019

Agile Therapeutics,Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - March 4, 2019

Agile Therapeutics,Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - January 23, 2019

12 3...5 Page 1 of 5

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 25, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: AGRX

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Results of Operations and...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Other Events

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Results of Operations and...

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by Maxim...

Agile Therapeutics,Inc. (NASDAQ:AGRX) Files An 8-K Other Events

Agile Therapeutics,Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material Definitive...

Agile Therapeutics,Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material Definitive...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY